Correlation Between Telkom Indonesia and TC BioPharm

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Telkom Indonesia and TC BioPharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Telkom Indonesia and TC BioPharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Telkom Indonesia Tbk and TC BioPharm Holdings, you can compare the effects of market volatilities on Telkom Indonesia and TC BioPharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Telkom Indonesia with a short position of TC BioPharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Telkom Indonesia and TC BioPharm.

Diversification Opportunities for Telkom Indonesia and TC BioPharm

0.85
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Telkom and TCBP is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding Telkom Indonesia Tbk and TC BioPharm Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TC BioPharm Holdings and Telkom Indonesia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Telkom Indonesia Tbk are associated (or correlated) with TC BioPharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TC BioPharm Holdings has no effect on the direction of Telkom Indonesia i.e., Telkom Indonesia and TC BioPharm go up and down completely randomly.

Pair Corralation between Telkom Indonesia and TC BioPharm

Considering the 90-day investment horizon Telkom Indonesia Tbk is expected to generate 0.15 times more return on investment than TC BioPharm. However, Telkom Indonesia Tbk is 6.71 times less risky than TC BioPharm. It trades about -0.22 of its potential returns per unit of risk. TC BioPharm Holdings is currently generating about -0.3 per unit of risk. If you would invest  2,023  in Telkom Indonesia Tbk on August 28, 2024 and sell it today you would lose (339.00) from holding Telkom Indonesia Tbk or give up 16.76% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Telkom Indonesia Tbk  vs.  TC BioPharm Holdings

 Performance 
       Timeline  
Telkom Indonesia Tbk 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Telkom Indonesia Tbk has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's essential indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
TC BioPharm Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days TC BioPharm Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unfluctuating performance in the last few months, the Stock's fundamental drivers remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Telkom Indonesia and TC BioPharm Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Telkom Indonesia and TC BioPharm

The main advantage of trading using opposite Telkom Indonesia and TC BioPharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Telkom Indonesia position performs unexpectedly, TC BioPharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TC BioPharm will offset losses from the drop in TC BioPharm's long position.
The idea behind Telkom Indonesia Tbk and TC BioPharm Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
CEOs Directory
Screen CEOs from public companies around the world
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account